Open AccessNeoadjuvant vs. Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer
Author(s) -
Mark L. Fuerst
Publication year - 2022
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000891836.89376.77
Subject(s) - medicine , lung cancer , oncology , neoadjuvant therapy , randomized controlled trial , nivolumab , taxane , chemotherapy , cancer , adjuvant therapy , surgery , breast cancer , immunotherapy